USPTO serial 79124462
ATTOQUANT DIAGNOSTICS
Reviewed by CopyMark Law Group
Reg. 4452951Status 404
- Filing date
- Status date
- Registration date
- Dec 24, 2013
- Examiner
- PEREZ, STEVEN M
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ATTOQUANT DIAGNOSTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julianne Abelman
Julianne Abelman Womble Bond Dickinson (US) LLP950 3rd Avenue, Suite 2400New York, NY 10022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological preparations for industrial and scientific purposes, namely, catalysts, reagents, diagnostic preparations except for human or veterinary medical purposes | SECTION 70 - CANCELLED | — |
| 005 | Pharmaceutical human and veterinary preparations for the treatment of cardiovascular diseases; diagnostic substances for medical purposes; sanitary preparations for medical purposes; dietetic substances, namely, food supplements adapted for medical use | SECTION 70 - CANCELLED | — |
| 042 | Scientific and technological services, namely, medical research and product development relating to the diagnosis and treatment of cardiovascular diseases; industrial analysis and research services, namely, research and development in the field of diagnosis and treatment of cardiovascular diseases | SECTION 70 - CANCELLED | — |
| 044 | Medical services, medical care, providing information in the medical field, medical testing of human and animal subjects for diagnostic or treatment purposes | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ATTOQUANT DIAGNOSTICS GMBH
- Other trademarks owned by APEIRON BIOLOGICS AG
- Other trademarks owned by APEIRON BIOLOGICS AG
- Other trademarks owned by APEIRON BIOLOGICS AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ATTOQUANT DIAGNOSTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 4, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 4, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 24, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jul 22, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 22, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 22, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 1, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 7, 2020 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Feb 7, 2020 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Feb 6, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 26, 2019 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 24, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 29, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 15, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 15, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 1, 2014 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 24, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 24, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 8, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 8, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 8, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 18, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 18, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 5, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 5, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 5, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 5, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 5, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 5, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 29, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 29, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 22, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jul 18, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 13, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 13, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 13, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 12, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 4, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 4, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 1, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |